Latest News
Latest News and Events
- All
- Events
- Featured
- Imspex Clinical
- Imspex Industrial
IMSPEX NEWS
PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics. ...
Read More →
Meet Robin Curnow
📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful ...
Read More →
Meet Trenton Stewart
IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and ...
Read More →
BioWales in London
Tuesday 5th March, Canary Wharf, London IMSPEX is excited to share that our Group CEO, John McKinley, will be delivering a presentation at the MediWales ...
Read More →
BioWales in London Pre-Event at The Shard
We’re pleased to announce that our Group CEO John McKinley will be participating in a panel discussion at Mathys & Squire IP Firm, located at The Shard ...
Read More →
IMSPEX Achieves New ISO Standard
We are pleased to announce that Imspex Diagnostic Ltd has achieved a significant milestone: the publication of a new ISO standard for Siloxane testing. Developed ...
Read More →
ONELAB Installation at the Amsterdam University Medical Center
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Amsterdam University Medical Center. This achievement is part of the ONELAB project, ...
Read More →
ISO Certification
Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement ...
Read More →
ONELAB Annual Meeting
IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the ...
Read More →
ONELAB Installations
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the ...
Read More →
Bevan Commission NHS 75 Conference
5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting ...
Read More →
LSX World Congress 2023
3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part ...
Read More →
AngloNordic Life Science Conference 2023
Our Group CEO John McKinley and PR, Social Media and Marketing Manager Amber Jacobs will be attending the 19th Annual AngloNordic Life Science Conference 2023 ...
Read More →
MediWales Connects NHS Collaboration Conference 2023
29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with ...
Read More →
BioWales in London
Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March ...
Read More →
Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th ...
Read More →
Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is ...
Read More →
Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic ...
Read More →
TOXI- Triage
In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency ...
Read More →
TOXI – Triage – DISPERSE exercise
On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a ...
Read More →
Leicester publication highlights Imspex and GC-IMS
Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and ...
Read More →
MediWales Innovation Awards 2022
Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about ...
Read More →
ONELAB
Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and ...
Read More →
Everyday household items that contain VOCs
VOCs are compounds that easily become gases or vapours and are made up of lots of different elements where one of the elements is carbon.
Read More →
GC-IMS highlights Imspex as Benchmark Technology in VOC Gas
We are very proud to have been highlighted by the ISO committe as the benchmark in VOC Gas technology.
Read More →
Bond Digital Health Partners with Imspex Group
Bond Digital Health and Imspex Diagnostics will be working together on an exciting new technology.
Read More →
What’s your FlavourSpec this Oktoberfest?
For brewers, having access to an instrument such as FlavourSpec could be business transformational.
Read More →
Co-Vid 19 Resilience Innovation success
Imspex Diagnostics was successful in its recent SMARTCymru application for funding to further establish its BreathSpec® technology’s potential as a channel to boost economic recovery ...
Read More →
Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer
Low level detection of Sulphur compounds in Natural gas using the Agilent Micro GC with Ion Mobility Spectrometer. G.A.S mbH re-engineered its sophisticated Ion Mobility ...
Read More →
BBC exposure for BreathSpec system
BreathSpec system and the BBC – How should we deal with a chemical attack? The BreathSpec system has been gaining much publicity recently. Read about ...
Read More →
Monitoring of Toxic Industrial Chemicals (TICs)
Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects ...
Read More →
Siloxanes in biogas gas from landfill waste
The generation of electricity from land fill is of increasing interest as a form of renewable energy to be used on site or sold to ...
Read More →
Authenticity of extra virgin olive oil
Want to know about how authentic extra virgin olive oil is? Keep reading… Extra virgin olive oil has always been a popular oil used in ...
Read More →
Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic
TOXI- Triage
In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency
TOXI – Triage – DISPERSE exercise
On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a
Leicester publication highlights Imspex and GC-IMS
Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and
MediWales Innovation Awards 2022
Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about
ONELAB
Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and